
The endocannabinoid system is a physiological system, which is responsible for the control of glucose and lipid-metabolism, as well as for the regulation of the body weight. The endocannabinoid receptors are distributed both in the central and peripher nervous system. Different studies provide evidence that an hyperactive endocannabinoid system is involved in the development of different cardiovascular risk factors. The pharmacological blockade of these cannabinoid receptors may represent a new approach for cardiometabolic risk management.
Blood Glucose, Body Weight, Overweight, Lipids, Europe, Diabetes Mellitus, Type 2, Piperidines, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators, Humans, Pyrazoles, Controlled Clinical Trials as Topic, Obesity, Insulin Resistance, Rimonabant, Energy Metabolism, Endocannabinoids
Blood Glucose, Body Weight, Overweight, Lipids, Europe, Diabetes Mellitus, Type 2, Piperidines, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators, Humans, Pyrazoles, Controlled Clinical Trials as Topic, Obesity, Insulin Resistance, Rimonabant, Energy Metabolism, Endocannabinoids
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
